Renewable Energy executives said in a conference call that under the terms of the agreement, the company is eligible for potential milestone payments of up to $1 billion as the first advanced clinical trial begins.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.